Preclinical Studies

Inhibiting Pyroptosis with Belnacasan Resensitizes Bladder Tumors to Chemotherapy

Preclinical mouse experiments demonstrate that belnacasan restores chemotherapy sensitivity, opening prospects for clinical evaluation in bladder and other cancers.